Skip to main content

Post-Market Overview

Ongoing obligations after registration

Obtaining product registration and a dealer's licence is the beginning — not the end — of regulatory compliance in Singapore. Both the registrant and licensed dealers have ongoing post-market obligations under the Health Products Act and HP(MD) Regulations 2010.


Summary of post-market obligations

ObligationWho it applies toKey reference
Adverse event reportingAll dealers (manufacturers, importers, wholesalers) and registrantsAdverse Event Reporting
FSCA reporting and actionRegistrants and dealersFSCA — When to Report
Change notificationRegistrantsChange Notification
Post-market surveillanceRegistrants (and manufacturers)PMS Obligations
Distribution recordsAll licensed dealersDistribution Records
Labelling complianceRegistrants and dealersLabelling Requirements
Advertising complianceAnyone advertising a medical deviceAdvertising Rules
Dealer's licence renewalLicensed dealersRenewing a Licence

The post-market feedback loop

Post-market obligations are not merely administrative — they are designed to feed safety information back to HSA and to manufacturers, enabling:

  • Early identification of device-related safety signals;
  • Rapid communication of field safety issues to healthcare professionals and patients;
  • Continuous improvement of device design and manufacturing;
  • Evidence generation for post-market surveillance reports and clinical evidence updates.

A robust post-market system is both a regulatory requirement and good clinical risk management practice.


HSA's post-market monitoring activities

HSA conducts active post-market monitoring, including:

  • Review of adverse event reports submitted by dealers and registrants;
  • Monitoring of international safety signals from reference agencies (TGA, FDA, MHLW, etc.) and IMDRF;
  • Market surveillance activities (inspections, sampling, testing);
  • Publication of risk communications when devices are subject to FSCA.

Official sources